This filing, Amendment No. 13 to the Schedule 13D, details transactions and ownership changes for INDIVIOR PLC by Two Seas Capital LP, Two Seas Capital GP LLC, and Sina Toussi (collectively, the "Reporting Persons"). The Reporting Persons, acting on behalf of the Litigation Fund and Global Fund, collectively hold 6,211...

This filing reports an amendment to a Schedule 13D for AIFU INC. by Infinew Limited and Katherine Wang. The amendment is due to the dilution of their ownership percentage from approximately 7.72% to 5.85% following AIFU INC.'s issuance of 5,000,000 Class B ordinary shares to Expansion Group Ltd on December 22, 2025. In...

This filing is an Amendment No. 1 to Schedule 13D, relating to the Class A Common Stock of Bimini Capital Management, Inc. Frank E. Jaumot, a Reporting Person and a director of the Issuer, is a United States citizen. The filing states that during the last five years, the Reporting Person has not been convicted in a cri...

This filing is an amendment to a previous Schedule 13D filing concerning LSB Industries, Inc. The amendment details changes in beneficial ownership, primarily involving Robert E. Robotti and associated entities. As of December 19, 2025, the aggregate beneficial ownership reported is 3,528,347 shares, representing 4.9% ...

Maase Inc. (the "Reporting Person") has filed Amendment No. 5 to its Schedule 13D/A for AIFU INC. This amendment reports a dilution in the Reporting Person's beneficial ownership and voting power due to the Issuer's issuance of 5,000,000 Class B ordinary shares to Expansion Group Ltd on December 22, 2025. The Reporting...

This filing serves as the final amendment to the Schedule 13D for Recursion Pharmaceuticals, Inc., marking an "exit filing" for the Reporting Persons. The amendment details changes in beneficial ownership of Class A Common Stock. Key events include the transfer of shares from MIC LP to MCAS on March 31, 2023. A signifi...

325 CAPITAL LLC, along with other reporting persons, has amended their Schedule 13D filing for MultiSensor AI Holdings, Inc. The amendment details significant acquisitions of the company's common stock. On December 19, 2025, the Issuer obtained Stockholder Approval, leading to a second closing on December 23, 2025. Thi...

This filing, Amendment No. 20 to the Schedule 13D for TORM plc, primarily concerns an amendment to Item 4 regarding a Sale and Purchase Agreement. On December 22, 2025, OCM Njord sold 14,156,061 Class A Shares to Hafnia at $22.00 per share, totaling $311,433,342 in cash proceeds. This transaction is the only one report...

Perceptive Advisors LLC and its affiliates (collectively, "Perceptive") have filed an amendment to Schedule 13D regarding their holdings in Trinity Biotech plc. The amendment details transactions including a Second Amendment to the Credit Agreement, which involves the issuance of a convertible promissory note to Credit...

This filing is an amendment to a Schedule 13D for Athira Pharma, Inc. (Ticker: ATHA), filed by Perceptive Advisors LLC and related entities. The amendment, dated December 23, 2025, reports changes in beneficial ownership. Perceptive Advisors LLC, Joseph Edelman, Perceptive Life Sciences Master Fund, Ltd., and Perceptiv...

Henry Posner III, through his filing, reports beneficial ownership of 340,000 shares of Power REIT common stock, representing 10.0% of the outstanding shares. These shares were acquired using personal funds for approximately $268,295. The filing indicates that Posner has sole voting and dispositive power over these sha...

This filing details an amendment to the Schedule 13D, originally filed on October 2, 2023, concerning the Common Stock of Putnam Master Intermediate Income Trust. Sit Investment Associates Inc. (SIA) and Sit Fixed Income Advisors II, LLC (SFI), collectively referred to as Sit Entities, have updated their beneficial own...

Henry Posner III, through his filing, reports beneficial ownership of 340,000 shares of Power REIT common stock, representing 10.0% of the outstanding shares. These shares were acquired using personal funds for approximately $268,295. The filing indicates that Posner has sole voting and dispositive power over these sha...

This filing serves as the final amendment to the Schedule 13D for Recursion Pharmaceuticals, Inc., marking an "exit filing" for the Reporting Persons. The amendment details changes in beneficial ownership of Class A Common Stock. Key events include the transfer of shares from MIC LP to MCAS on March 31, 2023. A signifi...

This filing is an amendment to a previous Schedule 13D filing concerning LSB Industries, Inc. The amendment details changes in beneficial ownership, primarily involving Robert E. Robotti and associated entities. As of December 19, 2025, the aggregate beneficial ownership reported is 3,528,347 shares, representing 4.9% ...

This filing details a Schedule 13D/A amendment for Flora Growth Corp. by reporting person Daniel Reis-Faria. As of December 23, 2025, Reis-Faria holds 6,425,951 common shares, representing 88.3% of the class. This holding is based on personal funds. On December 19, 2025, Reis-Faria was granted 471,208 stock options exe...

This filing is an amendment to a Schedule 13D filing for Atlas Energy Solutions Inc. The amendment details a multi-tranche, prepaid variable share forward sale transaction entered into by the Reporting Person, Gregory M. Shepard, on December 19, 2025. The transaction involves up to 425,000 shares of common stock and ob...

This filing details an amendment to the Schedule 13D, originally filed on October 2, 2023, concerning the Common Stock of Putnam Master Intermediate Income Trust. Sit Investment Associates Inc. (SIA) and Sit Fixed Income Advisors II, LLC (SFI), collectively referred to as Sit Entities, have updated their beneficial own...

This filing is an amendment (Amendment No. 31) to the Schedule 13D filed on March 18, 2015, by Sit Investment Associates Inc. and Sit Fixed Income Advisors II, LLC (collectively, "Sit Entities") relating to the Common Stock of First Trust Mortgage Income Fund. The Sit Entities collectively beneficially own 2,192,343 sh...

This filing is an Amendment No. 28 to Schedule 13D concerning the Common Stock of Bally's Corporation. Standard General L.P. has reported changes in its ownership. On December 22, 2025, a private investment vehicle managed by Standard General transferred 623,875 shares of the Issuer's Common Stock, valued at approximat...

This filing, Amendment No. 20 to the Schedule 13D for TORM plc, primarily concerns an amendment to Item 4 regarding a Sale and Purchase Agreement. On December 22, 2025, OCM Njord sold 14,156,061 Class A Shares to Hafnia at $22.00 per share, totaling $311,433,342 in cash proceeds. This transaction is the only one report...

Perceptive Advisors LLC and its affiliates (collectively, "Perceptive") have filed an amendment to Schedule 13D regarding their holdings in Trinity Biotech plc. The amendment details transactions including a Second Amendment to the Credit Agreement, which involves the issuance of a convertible promissory note to Credit...

This filing, Amendment No. 13 to the Schedule 13D, details transactions and ownership changes for INDIVIOR PLC by Two Seas Capital LP, Two Seas Capital GP LLC, and Sina Toussi (collectively, the "Reporting Persons"). The Reporting Persons, acting on behalf of the Litigation Fund and Global Fund, collectively hold 6,211...

Dany Vaiman, a Canadian citizen and Chief Financial Officer of Flora Growth Corp., has filed a Schedule 13D/A amendment detailing his ownership of the company's common stock. As of December 19, 2025, Vaiman holds 263,249 shares, representing 23.8% of the class. This filing follows a 39:1 reverse stock split effected by...

This filing is an amendment to a Schedule 13D for CEA Industries Inc., reporting changes in beneficial ownership. YZilabs Management Ltd. and associated individuals (Changpeng Zhao, Max S. Baucus, David J. Chapman, Teresa Marie Goody Guillen, Jiajin "Jane" He, Alex Odagiu, Matthew Roszak, and Ling "Ella" Zhang) have en...